Back
iShares US Insurance ETF Vs. Neurogene Industry Stock Comparison
Buy
53
IAK
iShares US Insurance ETF
Last Price:
124.99
Seasonality Move:
2.47%
Buy
75
NGNE
Neurogene
Last Price:
61.10
Seasonality Move:
58.98%
Buy
53
iShares US Insurance ETF (IAK)
is a Buy
Is iShares US Insurance ETF a Buy, Sell or Hold?
- The current iShares US Insurance ETF [IAK] share price is $124.75. The Score for IAK is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- IAK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Neurogene (NGNE)
is a Buy
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $66.00. The Score for NGNE is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- NGNE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IAK Stock Price Chart
What is iShares US Insurance ETF's stock price today?
-
The iShares US Insurance ETF share price today is $124.75
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IAK is experiencing slight selling pressure.
NGNE Stock Price Chart
IAK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.64 | Sell |
Relative Strength Index (14 RSI): | 35.62 | Sell |
Chaikin Money Flow: | -16971 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (127.1 - 131.6) | Sell |
Bollinger Bands (100): | (116.26 - 129.4) | Buy |
NGNE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.06 | Buy |
Relative Strength Index (14 RSI): | 75.97 | Buy |
Chaikin Money Flow: | 176225 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.28 - 53.36) | Buy |
Bollinger Bands (100): | (34.64 - 46.72) | Buy |
IAK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 127.52 | Sell |
20-day SMA: | 129.47 | Sell |
50-day SMA: | 128.75 | Sell |
200-day SMA: | 117.67 | Buy |
8-day EMA: | 127.22 | Sell |
20-day EMA: | 128.55 | Sell |
50-day EMA: | 127.44 | Sell |
200-day EMA: | 117.71 | Buy |
NGNE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 48.43 | Buy |
20-day SMA: | 49.56 | Buy |
50-day SMA: | 43.32 | Buy |
200-day SMA: | 37.93 | Buy |
8-day EMA: | 50.65 | Buy |
20-day EMA: | 48.54 | Buy |
50-day EMA: | 44.96 | Buy |
200-day EMA: | 36.96 | Buy |
iShares US Insurance ETF Earnings Growth & IAK Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $1.11 per share.
iShares US Insurance ETF Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Neurogene Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |